Stock SNGX SOLIGENIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Soligenix, Inc.

Equities

SNGX

US8342235053

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
0.3926 USD +0.67% Intraday chart for Soligenix, Inc. -1.58% -48.15%
05-16 Soligenix, Inc. Announces Positive Clinical Results from HyBryte Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma CI
05-10 Soligenix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SOLIGENIX, INC.
Bio Therapeutic Drugs
+0.67%-1.58%-48.15%-49.67%-96.45% 5.59M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. SNGX Stock
  4. Charts Soligenix, Inc.
  5. Relative Strength Chart